Europe — EMA

Ossica (Ibandronate Sodium Hydrate)

Ibandronate sodium hydrate, the active ingredient in Ossica, is a bisphosphonate presented as a oral tablet for osteoporosis treatment in postmenopausal women and men at risk of fracture.

Ibandronate Sodium Hydrate

Request sourcing

Pack/s

What is Ibandronate Sodium Hydrate?

Ibandronate sodium hydrate, the active ingredient in Ossica, is a bisphosphonate presented as a oral tablet for osteoporosis treatment in postmenopausal women and men at risk of fracture. It works by inhibiting bone resorption and strengthening bone density.

GNH USA supplies Ossica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and clinics worldwide.

What is Ibandronate Sodium Hydrate used for?

Ossica is a bisphosphonate that acts on skeletal metabolism - Post‑menopausal osteoporosis: improves ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...

What are the side effects of Ibandronate Sodium Hydrate?

Common ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →